All Business articles – Page 23
-
Business
Call for overhaul of EU rules on GMO clinical trial
Rules designed around genetically modified plants crops are holding back new cell and gene-based medicines
-
Business
Residents sue Arkema over contamination
French chemical giant accused of releasing toxic chemicals from US plant in the wake of hurricane Harvey
-
Business
US government urged to exercise drug patent rights
Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
-
Business
Long road to recovery for Puerto Rico pharmaceuticals
As inhabitants begin to rebuild their lives after the devastation of hurricane Maria, the island’s drug manufacturers are recovering slowly
-
Business
US state passes law blocking generic drug price-gouging
Despite industry opposition, Maryland will be able to fine companies for ‘excessive and unjustified’ price increases
-
Business
Amgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
Business
US probes opioid manufacturers
Attorneys general from 41 states will investigate companies over alleged fraudulent marketing and distribution of painkillers
-
Business
Helium and rubber added to EU critical raw materials list
New classification sees nine materials pass threshold of supply risk, while two are downgraded
-
Business
BASF to buy Solvay’s polyamide business
€1.6bn deal covers 2400 employees at sites in Europe, Asia and the Americas
-
Business
Teva to sell off women’s health businesses for $1.4bn
Deals continue Teva’s bid to get rid of non-core businesses and raise cash to service its debts
-
Business
Industry intervenes in chemical regulation lawsuits
Trade groups back up US EPA against environmental campaigners’ complaints of relaxation in new rules
-
Business
Allergan sidesteps patent review with tribal deal
Native Americans agree to use sovereign immunity to protect intellectual property from double challenge
-
Business
Alexion axes 20% of its global workforce
600 jobs lost amid restructure as firm moves to Boston life sciences hub
-
Business
AkzoNobel paint plant is ‘world’s most sustainable’
Biomass and solar-powered UK factory will recycle water and solvents, and is more flexible to reduce waste
-
Business
Chemours reaches truce in pollution investigation
Company will provide authorities with data on perfluorinated compound emissions into drinking water
-
Business
Hurricanes’ chemical consequences
Gulf coast petrochemical plants move to restart operations, while concerns persist about the fallout from hurricane Irma
-
Business
Teva sells off contraceptive device in $1.1bn deal
CooperSurgical to acquire Paragard as Teva seeks to offload assets
-
Business
HB Fuller targets growth with trio of deals
Adhesives manufacturer will buy one Brazilian and two US glue companies
-
Business
Takeda tightens focus on core areas with multiple deals
Japanese firm is remodelling its R&D efforts through collaboration and licensing deals, and selling off non-core businesses
-
Business
FDA warns Pfizer subsidiary over Epipen malfunctions
Manufacturer did not fully investigate reports of patients dying after auto-injector failures